Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordeev

Showing results (561-570 of 583) with videos related to

Pageof 59
Sort By:
Antibiotics (Basel, Switzerland)|October 27, 2023
<i>Ligilactobacillus salivarius</i> 7247 Strain: Probiotic Properties and Anti-<i>Salmonella</i> Effect with PrebioticsVyacheslav M Abramov, Igor V Kosarev, Andrey V Machulin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 10, 2020
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical TrialAndrey A Ivashchenko, Kirill A Dmitriev, Natalia V Vostokova, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
<i>Limosilactobacillus fermentum</i> 3872 That Produces Class III Bacteriocin Forms Co-Aggregates with the Antibiotic-Resistant <i>Staphylococcus aureus</i> Strains and Induces Their Lethal DamageVyacheslav M Abramov, Igor V Kosarev, Andrey V Machulin, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 29, 2021
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical studyNikita V Lomakin, Bulat A Bakirov, Denis N Protsenko, et al.
Antibiotics (Basel, Switzerland)|January 8, 2025
Consortium of <i>Lactobacillus crispatus</i> 2029 and <i>Ligilactobacillus salivarius</i> 7247 Strains Shows In Vitro Bactericidal Effect on <i>Campylobacter jejuni</i> and, in Combination with Prebiotic, Protects Against Intestinal Barrier DysfunctionVyacheslav M Abramov, Igor V Kosarev, Andrey V Machulin, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
A Novel <i>Bifidobacterium longum</i> Subsp. <i>longum</i> T1 Strain from Cow's Milk: Homeostatic and Antibacterial Activity against ESBL-Producing <i>Escherichia coli</i>Andrey V Machulin, Vyacheslav M Abramov, Igor V Kosarev, et al.
Antibiotics (Basel, Switzerland)|January 22, 2024
Anti-<i>Salmonella</i> Defence and Intestinal Homeostatic Maintenance In Vitro of a Consortium Containing <i>Limosilactobacillus fermentum</i> 3872 and <i>Ligilactobacillus salivariu</i>s 7247 Strains in Human, Porcine, and Chicken EnterocytesVyacheslav M Abramov, Igor V Kosarev, Andrey V Machulin, et al.
Genome Biology|January 12, 2026
SARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunitiesViorel Munteanu, Michael A Saldana, David Dreifuss, et al.
The Lancet. Global Health|December 17, 2020
Assessment of the validity of the measurement of newborn and maternal health-care coverage in hospitals (EN-BIRTH): an observational studyLouise Tina Day, Qazi Sadeq-Ur Rahman, Ahmed Ehsanur Rahman, et al.
The Lancet. Global Health|March 22, 2020
Randomised comparison of two household survey modules for measuring stillbirths and neonatal deaths in five countries: the Every Newborn-INDEPTH studyJoseph Akuze, Hannah Blencowe, Peter Waiswa, et al.
Pageof 59

Showing results (561-570 of 583) with videos related to

Sort By:
Pageof 59
Antibiotics (Basel, Switzerland)|October 27, 2023
<i>Ligilactobacillus salivarius</i> 7247 Strain: Probiotic Properties and Anti-<i>Salmonella</i> Effect with PrebioticsVyacheslav M Abramov, Igor V Kosarev, Andrey V Machulin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 10, 2020
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical TrialAndrey A Ivashchenko, Kirill A Dmitriev, Natalia V Vostokova, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
<i>Limosilactobacillus fermentum</i> 3872 That Produces Class III Bacteriocin Forms Co-Aggregates with the Antibiotic-Resistant <i>Staphylococcus aureus</i> Strains and Induces Their Lethal DamageVyacheslav M Abramov, Igor V Kosarev, Andrey V Machulin, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 29, 2021
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical studyNikita V Lomakin, Bulat A Bakirov, Denis N Protsenko, et al.
Antibiotics (Basel, Switzerland)|January 8, 2025
Consortium of <i>Lactobacillus crispatus</i> 2029 and <i>Ligilactobacillus salivarius</i> 7247 Strains Shows In Vitro Bactericidal Effect on <i>Campylobacter jejuni</i> and, in Combination with Prebiotic, Protects Against Intestinal Barrier DysfunctionVyacheslav M Abramov, Igor V Kosarev, Andrey V Machulin, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
A Novel <i>Bifidobacterium longum</i> Subsp. <i>longum</i> T1 Strain from Cow's Milk: Homeostatic and Antibacterial Activity against ESBL-Producing <i>Escherichia coli</i>Andrey V Machulin, Vyacheslav M Abramov, Igor V Kosarev, et al.
Antibiotics (Basel, Switzerland)|January 22, 2024
Anti-<i>Salmonella</i> Defence and Intestinal Homeostatic Maintenance In Vitro of a Consortium Containing <i>Limosilactobacillus fermentum</i> 3872 and <i>Ligilactobacillus salivariu</i>s 7247 Strains in Human, Porcine, and Chicken EnterocytesVyacheslav M Abramov, Igor V Kosarev, Andrey V Machulin, et al.
Genome Biology|January 12, 2026
SARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunitiesViorel Munteanu, Michael A Saldana, David Dreifuss, et al.
The Lancet. Global Health|December 17, 2020
Assessment of the validity of the measurement of newborn and maternal health-care coverage in hospitals (EN-BIRTH): an observational studyLouise Tina Day, Qazi Sadeq-Ur Rahman, Ahmed Ehsanur Rahman, et al.
The Lancet. Global Health|March 22, 2020
Randomised comparison of two household survey modules for measuring stillbirths and neonatal deaths in five countries: the Every Newborn-INDEPTH studyJoseph Akuze, Hannah Blencowe, Peter Waiswa, et al.
Pageof 59